ÂÜÀòÂÒÂ×

Greg Hobelmann is a highly experienced medical professional with a strong focus on addiction treatment and psychiatry. Currently serving as Co-CEO/President and Senior Vice President, Chief Clinical and Medical Officer at Ashley Addiction Treatment since July 2016, Greg has also held various roles including Staff Psychiatrist and Chief Clinical and Medical Officer. In addition to these positions, Greg is a Board Member of the National Association of Addiction Treatment Providers and a part-time faculty member in the Department of Psychiatry and Behavioral Sciences at The Johns Hopkins University. Past experience includes advisory roles for New Day Campaign, staff physician at Father Martin's Ashley, and faculty member at The Johns Hopkins University in the Department of Anesthesiology and Critical Care Medicine. Academic qualifications encompass multiple degrees from The Johns Hopkins University, including Chief Resident in Psychiatry and a Master of Public Health from Johns Hopkins Bloomberg School of Public Health, complemented by a medical degree from the University of Maryland School of Medicine and a Bachelor of Science in Biology from Georgetown University.